Systematic transcriptome-wide meta-analysis across endocrine disrupting chemicals reveals shared and unique liver pathways, gene networks, and disease associations

By sjmartinez • January 25, 2024

Mohamed MF, Qian Y, D'Cunha R, Sligh T, Ferris LK, Eldred A, Levy GF, Hao S, Gannu S, Rizzo DG, Liu W, Jazayeri S, Sofen H, Carcereri De Prati R. Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clin Transl Sci. 2024 Jan;17(1):e13682. doi: 10.1111/cts.13682. Epub 2023 Dec 19. PMID: 38112262; PMCID: PMC10766045.

Tags: Dermatology, Olive View DoM, Publications

Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy

Park A, Castillo J. Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy. Dermatol Surg. 2025 Jul 15. doi: 10.1097/DSS.0000000000004773.[...]

Phase I Trial to Evaluate the Safety of Intralesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

Wang CJ, Bang A, Chowdhury S, Leslie KS, Lang UE, Shimoda M, Henrich TJ, Hoh R, Deeks SG, Wang C, Deitchman AN, Couey P, Maurer[...]

Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer

Jung SY, Pellegrini M, Tan X, Yu H. Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer. Aging (Albany NY). 2025[...]